Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

This study has been terminated.
(Pfizer has terminated the execution of this protocol)
Sponsor:
Collaborator:
Pfizer
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00836069
First received: February 3, 2009
Last updated: May 29, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)